Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Johnstone

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Hypertension|April 1, 1996
The pathophysiology of the onset of morning cardiovascular eventsM T Johnstone, M Mittleman, G Tofler, et al.
Diabetes, Obesity & Metabolism|January 15, 2008
Evidence for functional expression of vascular angiotensin II type 2 receptors in patients with insulin resistanceD G Brillante, A J O'Sullivan, M T Johnstone, et al.
American Journal of Hypertension|April 1, 1996
The emerging role of chronotherapeutics in managing hypertension. Panel discussionH R Black, M H Smolensky, M T Johnstone, et al.
European Journal of Clinical Investigation|March 19, 2009
Predictors of inotropic and chronotropic effects of NG-monomethyl-L-arginineD G Brillante, A J O'Sullivan, M T Johnstone, et al.
Circulation|July 6, 2000
Images in cardiovascular medicine. Ventricular tachycardia: a complication of an intramyocardial echinococcal cystM T Johnstone, M Notarianni, M Charlamb, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
Quantification of cholesteryl esters in human and rabbit atherosclerotic plaques by magic-angle spinning (13)C-NMRS Peng, W Guo, J D Morrisett, et al.
Journal of the American College of Cardiology|January 1, 1993
Methylene blue inhibits the antithrombotic effect of nitroglycerinM T Johnstone, J Y Lam, L Lacoste, et al.
Thrombosis Research|June 15, 1993
PPACK attenuates plasmin-induced changes in endothelial integrityL E Rabbani, M T Johnstone, M A Rudd, et al.
Journal of the American College of Cardiology|March 1, 1996
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusS B Williams, J A Cusco, M A Roddy, et al.
Circulation|December 1, 1991
Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressinM A Rudd, M T Johnstone, L E Rabbani, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Hypertension|April 1, 1996
The pathophysiology of the onset of morning cardiovascular eventsM T Johnstone, M Mittleman, G Tofler, et al.
Diabetes, Obesity & Metabolism|January 15, 2008
Evidence for functional expression of vascular angiotensin II type 2 receptors in patients with insulin resistanceD G Brillante, A J O'Sullivan, M T Johnstone, et al.
American Journal of Hypertension|April 1, 1996
The emerging role of chronotherapeutics in managing hypertension. Panel discussionH R Black, M H Smolensky, M T Johnstone, et al.
European Journal of Clinical Investigation|March 19, 2009
Predictors of inotropic and chronotropic effects of NG-monomethyl-L-arginineD G Brillante, A J O'Sullivan, M T Johnstone, et al.
Circulation|July 6, 2000
Images in cardiovascular medicine. Ventricular tachycardia: a complication of an intramyocardial echinococcal cystM T Johnstone, M Notarianni, M Charlamb, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 16, 2000
Quantification of cholesteryl esters in human and rabbit atherosclerotic plaques by magic-angle spinning (13)C-NMRS Peng, W Guo, J D Morrisett, et al.
Journal of the American College of Cardiology|January 1, 1993
Methylene blue inhibits the antithrombotic effect of nitroglycerinM T Johnstone, J Y Lam, L Lacoste, et al.
Thrombosis Research|June 15, 1993
PPACK attenuates plasmin-induced changes in endothelial integrityL E Rabbani, M T Johnstone, M A Rudd, et al.
Journal of the American College of Cardiology|March 1, 1996
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitusS B Williams, J A Cusco, M A Roddy, et al.
Circulation|December 1, 1991
Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressinM A Rudd, M T Johnstone, L E Rabbani, et al.
Pageof 2